|
|
|
|
|
|
| Reametrix scouts for strategic partners | 16-NOV-09 |
|
| Reametrix, a Bangalore-based company that provides basic research and assay development services to biotechnology and pharmaceutical companies, is scouting for strategic partners to take TriTstat, a critical diagnostic product for managing HIV patients, to the global markets. |
|
|
|
| Glenmark Generics gets US FDA nod for Ciclopirox Olamine | 14-NOV-09 |
|
| Glenmark Generics today said it has received ANDA (abbreviated new drug application) approval from the United States Food and Drug Administration for Ciclopirox Olamine cream, used in the treatment of dermatological infections. |
|
|
|
| Aurobindo gets US FDA nod | 19-SEP-09 |
|
| Aurobindo Pharma Limited has received the tentative approval for Atomoxetine Hydrochloride capsules in 10mg, 18mg, 25mg, 40mg, 60mg, 80mg, and 100mg strengths. |
|
|
|
|
|
|
| Suven Life gets two more US patents for NCEs | 14-SEP-09 |
|
| Suven Life Sciences Limited, a Hyderabad-based biopharmaceutical company specialising in central nervous system (CNS) diseases, has received patents for two new chemical entities (NCEs) from the US Patent office. |
|
|
|
|
|
|
| Aurobindo gets FDA nod for muscle relaxant | 07-AUG-09 |
|
| Aurobindo Pharma Limited, a Hyderabad-based manufacturer of generic pharmaceuticals and active pharmaceutical ingredients (APIs), has received the final approval for carisoprodol tablets USP in 350mg strength from the US Food and Drug Administration (US FDA), taking its total number of abbreviated new drug application (ANDA) approvals from the US drug regulator to 100.
Carisoprodol tablets USP 350mg, the generic equivalent to Soma Tablets of Meda Pharmaceuticals, are muscle relaxants and are |
|
|
|
| Glenmark gets US nod for ointment | 31-JUL-09 |
|
| Drug firm Glenmark Pharmaceuticals today said it has received approval from the US Food and Drug Administration (FDA) for an ointment used in treating skin problems. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Suven Life high on US FDA nod | 07-MAY-09 |
|
| Suven Life Sciences hit the 10 per cent upper circuit today to close at Rs 15.85 after the US Food and Drug Administration cleared its Andhra Pradesh unit. |
|
|
|
Content Guide
